Advanced Technologies in Prenatal Diagnosis: Closing the Diagnostic Gap with Genome Analysis

Discription

Traditional prenatal testing methods, including CMA and exome sequencing, can yield informative results, but often leave diagnostic gaps. Genome analysis is helping to close those gaps by identifying clinically significant variants that standard approaches may miss, such as small CNVs, short tandem repeat expansions, mitochondrial variants, and others. This webinar will highlight the clinical utility of prenatal genome testing, outline the technical advantages that contribute to higher diagnostic yield, and examine its implications for patient counseling, perinatal care, and informed consent. Real-world case examples will demonstrate how genome analysis supports more informed and confident decision-making in prenatal care.

Speakers

Allan J Fisher, MD, FACOG, FACMG

Medical Director, Variantyx 

Christine Stanely, PhD, FACMG

Chief Director, Clinical Genomics, Variantyx 

Jane Schuette, MS CGC 

Manager of Prenatal Analysis and Clinical Genomics Team Lead, Variantyx 

This webinar is independently developed and presented by Variantyx. 

About the Industry-Supported Virtual Forums

The Society for Maternal-Fetal Medicine’s (SMFM) Industry-Supported Virtual Forum Series allows companies to share educational content and product-related information relevant to the maternal-fetal medicine community. These sessions are independently developed and are not certified for CME credit.

Disclaimer: The content of this independent presentation is neither endorsed nor supported by SMFM and does not represent official SMFM guidelines. It is offered to SMFM members for informational purposes only.